PMC5778717_01
Planar technetium-99m phytate scintigraphy anterior (a) and posterior (b) view. Maximum intensity projection images of gallium 68 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-NaI3-octreotide-positron emission tomography/computed tomography (c) and technetium-99m phytate single-photon emission computed tomography/computed tomography (b) showing similar lesions. Maximum intensity projection image of single-photon emission computed tomography/computed tomography (d) more lesions compared with planar views (a and b) due to improved sensitivity. Displacement of the biggest lesion in the left flank due to bowel movement
WJNM-17-56-g001.jpg
PMC5778717_01_WJNM-17-56-g001.jpg
F1
To further differentiate NET from splenosis, technetium (Tc)-99m phytate single-photon emission computed tomography (SPECT)/CT scan was performed [Figure 1].
Suspicious lesions on gallium 68 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid- NaI3-octreotide-positron emission tomography/computed tomography (a-c) with respective correlates on technetium-99m phytate single-photon emission computed tomography/computed tomography (d-f) confirming the diagnosis of splenosis
WJNM-17-56-g002.jpg
PMC5778717_01_WJNM-17-56-g002.jpg
F2
All suspicious lesions on Ga-68 DOTA-NOC-PET/CT also demonstrated tracer uptake on Tc-99m phytate scintigraphy making the diagnosis of splenosis more likely [Figure 2].